Premium Content
Subscriber only BIOTECHNOLOGY firm CannaPacific and the national science agency, CSIRO, have announced a partnership to trial novel encapsulation technologies for more effective medicinal cannabinoids. Medicinal cannabis company CannaPacific operates a medicinal cannabis supply chain, including a licenced cultivation facility nestled in the Lismore LGA, featuring a 10,000 sqm Dutch glasshouse and high-security outdoor cultivation area. Current oral medicinal cannabis products have low and inconsistent bioavailability - which refers to the proportion of the medicinal substance absorbed by the body in order to have an active effect - leading to inconsistent therapeutic benefit. CannaPacific has commenced a proof-of-concept study of the encapsulation technology, developed in collaboration between CSIRO s Probing Biosystems Future Science Platform and The University of Queensland s Australian Institute for Bioengineering and Nanotechnology (AIBN).